A novel implant has shown it can slow vision loss in macular telangiectasia type 2, offering the first approved treatment for this rare disorder. Credit: Stock
Phase 3 clinical trial results from Sc… [+6454 chars]
First-Ever Treatment for Rare Eye Disease Wins FDA Approval After Landmark Trials - SciTechDaily
Phase 3 clinical trial results from Scripps Research and its collaborators supported FDA approval of ENCELTO, the first cell-based treatment for the neurodegenerative retinal disease known as MacTel. For individuals with macular telangiectasia type 2 (MacTel)…
Source:SciTechDaily
Published:
Related News
:max_bytes(150000):strip_icc()/6BalanceMovestoBuildStrengthandStabilityAfter50-5e555f6fef74433db518b653b2c3a6d2.gif)
6 Balance Exercises to Boost Strength and Stability After 50, According to Fitness Experts - EatingWell
Discover 6 balance exercises for strength and stability after 50. Build confidence, prevent falls and move safely with expert-backed exercises.
Eatingwell.com•https://www.facebook.com/EatingWell/
Shrews Can Shrink Their Brains by 30%. Here's How They Grow It Back. - ScienceAlert
In preparation for winter, the common shrew (Sorex araneus) shrinks its brain by 30 percent to conserve precious energy.
ScienceAlert•Jess Cockerill
Six viruses detected at high levels in Kansas community’s wastewater - hayspost.com
Image Pixaby Lawrence sees early flu peak as some health care provider
hays Post